PSQ Holdings, Inc. filed a Form 8-K on November 13, 2026, disclosing that the New York Stock Exchange notified the company on November 9, 2026 that it had commenced proceedings to delist the company's Class A common stock and public warrants, with trading in both securities suspended immediately upon that notification.

Key Highlights

  • Trading suspended immediately: NYSE Regulation suspended trading in PSQ Holdings' Class A common stock and warrants effective November 9, 2026.
  • Market cap deficiency cited: The delisting of the common stock follows non-compliance with Section 802.01B of the NYSE Listed Company Manual, which requires a minimum average global market capitalization of at least $15 million over a consecutive 30 trading day period.
  • Warrants flagged separately: The warrants, each exercisable for 1/15th of one share of Class A common stock at $172.50 per share, were deemed no longer suitable for listing due to "abnormally low selling price" levels under Section 802.01D.
  • No appeal planned: According to the filing, "the Company does not intend to appeal NYSE Regulation's determination to delist the Securities."
  • OTC trading began November 10, 2026: Both securities moved to the Pink Limited Market operated by OTC Markets Group, Inc., trading under symbols "PSQH" and "PSQHW."
  • OTCQB listing sought: The company disclosed it is seeking to list its securities on the OTCQB Venture Market, though no assurance of acceptance was given.

NYSE Delisting Action Against PSQ Holdings and Its Securities

PSQ Holdings, Inc., a Delaware-incorporated emerging growth company headquartered in Bozeman, Montana, operates under NYSE:PSQH. On November 9, 2026, NYSE Regulation notified the company that it had determined to commence delisting proceedings against both the company's Class A common stock, par value $0.0001 per share, and its publicly traded warrants. The common stock failed to maintain the minimum average global market capitalization threshold of $15 million over a consecutive 30 trading day period as required by Section 802.01B of the NYSE Listed Company Manual. The warrants were separately flagged under Section 802.01D for "abnormally low selling price" levels.

Trading in both the common stock and the warrants was suspended by the NYSE immediately upon the November 9, 2026 notification. The filing states that NYSE Regulation will apply to the SEC to formally delist the securities upon completion of applicable procedures. The company disclosed it has a right to request a review of NYSE Regulation's determination by a Committee of the Board of Directors of the NYSE, provided a written request is filed with the Corporate Secretary of the NYSE within ten business days of receiving the notice. However, the company stated it does not intend to exercise that right.

Beginning November 10, 2026, both securities commenced trading on the Pink Limited Market under the OTC Markets Group, with the common stock trading as "PSQH" and the warrants as "PSQHW." The filing characterized the Pink Market as "a significantly more limited market than the NYSE" and noted that quotation there "will likely result in a less liquid market for existing and potential holders of the Securities." The company is additionally pursuing a listing on the OTCQB Venture Market, though the filing cautions that no assurance of acceptance on that market can be provided. The Form 8-K was signed by James Giudice, Chief Legal Officer, on November 13, 2026.

What Was Disclosed

PSQ Holdings disclosed via an Item 3.01 Form 8-K that NYSE Regulation commenced delisting proceedings against its common stock and warrants on November 9, 2026, citing market capitalization deficiency and abnormally low warrant prices. Trading moved to the OTC Pink Market the following day, and no appeal is planned.